SEC Form 4 · accession 0001493152-18-013387
Nobilis Health Corp. · HLTH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Harry Joseph Fleming
Officer — Chief Executive Officer · Director
Period of report
Sep 13, 2018
Accepted (ET)
Sep 17, 2018 · 5:27 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001409916
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Restricted Stock UnitsF1,F4 | — | Sep 13, 2018 | A | 235,000 | A | Sep 13, 2021 | — | Common Stock | 235,000 | 235,000 | D |
| Stock Options (Right to Buy)F3,F2 | $0.84 | Sep 13, 2018 | A | 150,000 | A | — | Sep 13, 2028 | Common Stock | 150,000 | 150,000 | D |
Explanation of responses
- F1Each RSU represents the contingent right to receive either (i) one share of common stock upon vesting of the RSU or (ii) a cash payment in an amount equal to the U.S. dollar equivalent of the market price per unit on the vesting date.
- F2Stock options were granted at an exercise price of $0.84 per share (the average volume weighted average price ("VWAP") for the five business day period ending on the business day prior to the date of grant).
- F3Stock options vest in twelve equal quarterly installments, on the last date of each calendar quarter, beginning on December 31, 2018 and ending on September 30, 2021.
- F4None.